COLACI, Michele
 Distribuzione geografica
Continente #
NA - Nord America 5.119
AS - Asia 1.737
EU - Europa 1.275
SA - Sud America 386
AF - Africa 201
AN - Antartide 1
Continente sconosciuto - Info sul continente non disponibili 1
OC - Oceania 1
Totale 8.721
Nazione #
US - Stati Uniti d'America 4.973
SG - Singapore 911
CN - Cina 590
IE - Irlanda 488
BR - Brasile 352
IT - Italia 331
CI - Costa d'Avorio 154
CA - Canada 119
RU - Federazione Russa 112
UA - Ucraina 80
KR - Corea 68
DE - Germania 47
GB - Regno Unito 43
IN - India 37
FR - Francia 34
VN - Vietnam 22
FI - Finlandia 20
SE - Svezia 18
CH - Svizzera 17
AT - Austria 16
AR - Argentina 14
MX - Messico 14
NG - Nigeria 14
BD - Bangladesh 13
IQ - Iraq 13
NL - Olanda 13
SN - Senegal 13
UZ - Uzbekistan 12
CZ - Repubblica Ceca 10
ID - Indonesia 9
TR - Turchia 9
EC - Ecuador 8
GR - Grecia 8
HK - Hong Kong 8
JP - Giappone 8
LB - Libano 8
MA - Marocco 8
PL - Polonia 8
ES - Italia 7
AE - Emirati Arabi Uniti 5
DO - Repubblica Dominicana 5
SA - Arabia Saudita 5
ZA - Sudafrica 5
PK - Pakistan 4
BE - Belgio 3
BG - Bulgaria 3
PY - Paraguay 3
RO - Romania 3
BA - Bosnia-Erzegovina 2
BY - Bielorussia 2
CO - Colombia 2
DZ - Algeria 2
GT - Guatemala 2
JM - Giamaica 2
KZ - Kazakistan 2
LK - Sri Lanka 2
LT - Lituania 2
PE - Perù 2
RS - Serbia 2
SY - Repubblica araba siriana 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
AM - Armenia 1
AU - Australia 1
BH - Bahrain 1
BO - Bolivia 1
CL - Cile 1
CR - Costa Rica 1
CW - ???statistics.table.value.countryCode.CW??? 1
DK - Danimarca 1
EE - Estonia 1
ET - Etiopia 1
GE - Georgia 1
GS - Georgia del Sud e Isole Sandwich Australi 1
HR - Croazia 1
HU - Ungheria 1
IL - Israele 1
JO - Giordania 1
KE - Kenya 1
LU - Lussemburgo 1
MK - Macedonia 1
NI - Nicaragua 1
OM - Oman 1
PH - Filippine 1
PS - Palestinian Territory 1
TG - Togo 1
TL - Timor Orientale 1
VE - Venezuela 1
Totale 8.721
Città #
Dallas 909
Santa Clara 840
Chandler 736
Singapore 495
Dublin 488
Chicago 195
Houston 169
Boardman 165
Abidjan 154
Ashburn 135
Lawrence 126
Cambridge 122
Andover 120
Hefei 116
Nanjing 115
New York 114
Jacksonville 83
Los Angeles 82
Toronto 77
Des Moines 75
Seoul 68
Beijing 62
Catania 60
Wilmington 40
Civitanova Marche 35
The Dalles 35
Columbus 34
Ottawa 31
Saint Petersburg 29
Shenyang 27
São Paulo 26
Jiaxing 25
Nanchang 25
Hebei 23
Bremen 22
Falls Church 22
Ann Arbor 20
Council Bluffs 20
Milan 18
Kochi 17
Palermo 16
Tianjin 15
Abuja 14
Changsha 13
Dakar 13
San Francisco 13
Belo Horizonte 12
Rio de Janeiro 12
Brooklyn 11
Jesi 10
Seattle 10
Washington 10
Brno 9
Jakarta 9
Kunming 9
Norwalk 9
Atlanta 8
Hong Kong 8
Jinan 8
Tokyo 8
Cesa 7
Guangzhou 7
Lappeenranta 7
Nuremberg 7
Paterno 7
Rome 7
Stockholm 7
Turku 7
Baghdad 6
Boston 6
Chennai 6
Edinburgh 6
Giarre 6
Helsinki 6
Ho Chi Minh City 6
Munich 6
Reggio Emilia 6
Vienna 6
Brasília 5
Changchun 5
Curitiba 5
Den Haag 5
Manchester 5
Messina 5
Mexico City 5
Pune 5
Taubaté 5
Turin 5
Warsaw 5
Calgary 4
Campinas 4
Johannesburg 4
Latina 4
London 4
Mauá 4
Pennisi 4
Princeton 4
Quito 4
Riyadh 4
San Jose 4
Totale 6.387
Nome #
Established coronary artery disease in systemic sclerosis compared to type 2 diabetic female patients: a cross-sectional study 155
Endocrine disorders associated with hepatitis C virus chronic infection 140
Clinical, serological and radiological features of a prospective cohort of Interstitial Pneumonia with Autoimmune Features (IPAF) patients 108
COVID-19-related retinal microvasculopathy and systemic implications in patients with severe disease: results from the Methuselah study 100
A New Method for the Assessment of Myalgia in Interstitial Lung Disease: Association with Positivity for Myositis-Specific and Myositis-Associated Antibodies 100
Adult-onset Still’s disease: an Italian multicentre retrospective observational study of manifestations and treatments in 245 patients 90
"Usual" interstitial pneumonia with autoimmune features: a prospective study on a cohort of idiopathic pulmonary fibrosis patients 89
Neutrophil-to-Lymphocyte Ratio (NLR) Is a Promising Predictor of Mortality and Admission to Intensive Care Unit of COVID-19 Patients 87
ADHERENCE TO THERAPY IN RHEUMATIC PATIENTS TREATED WITH SUBCUTANEOUS BIOLOGICS 85
Heart involvement and systemic sclerosis 85
Patients with Interstitial Lung Disease Secondary to Autoimmune Diseases: How to Recognize Them? 84
Reduction of carotid baroreceptor sensitivity in systemic sclerosis 82
Carotidynia Possibly due to Localized Vasculitis in a Patient with Latent Mycobacterium tuberculosis Infection 82
COMPARISON BETWEEN PATIENTS WITH IDIOPATHIC PULMONARY FIBROSIS AND INTERSTITIAL PNEUMONIA WITH AUTOIMMUNE FEATURES: A PROSPECTIVE COHORT 82
Associations between Systemic Sclerosis and Thyroid Diseases 81
Haematological Malignancies in Systemic Sclerosis Patients: Case Reports and Review of the World Literature 81
Efficacia di terapia con immunoassorbimento con proteina A dello stafilococco e talidomide in un caso di dermatomiosite refrattaria. 80
Alveolar haemorrhage in ANCA-associated vasculitis: Long-term outcome and mortality predictors 79
Covid-19 And Rheumatic Autoimmune Systemic Diseases: Role of Pre-Existing Lung Involvement and Ongoing Treatments 78
Age at diagnosis influences the clinical phenotype, treatment strategies and outcomes in patients with giant cell arteritis: results from the observational GCAGE study on a large cohort of 1004 patients 78
Aortic pulse wave velocity measurement in systemic sclerosis patients 77
Chemokines in the pathogenesis and as therapeutical markers and targets of HCV chronic infection and HCV extrahepatic manifestations 77
Cardiovascular risk and prostanoids in systemic sclerosis 76
Cardiac involvement in systemic sclerosis: Identification of high-risk patient profiles in different patterns of clinical presentation 76
[CXCR3 and CXCL10 in autoimmune thyroiditis] 75
Myositis-Specific and Myositis-Associated Antibodies in Fibromyalgia Patients: A Prospective Study 74
ADULT ONSET STILL'S DISEASE: A MULTICENTER RETROSPECTIVE COHORT STUDY OF 233 ITALIAN PATIENTS 74
Aortic root dilation in associated with the reduction in capillary density observed at nailfold capillaroscopy in SSc patients 74
Breast cancer in systemic sclerosis: Results of a cross-linkage of an Italian Rheumatologic Center and a population-based Cancer Registry and review of the literature. 73
Novel Therapies for Thyroid Autoimmune Diseases 73
Nailfold videocapillaroscopy alterations in dermatomyositis and systemic sclerosis: Toward identification of a specific pattern 73
The Morphological Domain Does Not Affect the Rate of Progression to Defined Autoimmune Diseases in Patients With Interstitial Pneumonia With Autoimmune Features 73
Vascular dysfunction of COVID-19 is partially reverted in the long-term 73
The Impaired Elasticity of Large Arteries in Systemic Sclerosis Patients 72
Etiopathogenesis of Systemic Sclerosis: Role of Human Parvovirus B19 72
Antiendothelial cell antibodies induce apoptosis of bone marrow endothelial progenitors in systemic sclerosis. 72
Elevated Troponin Serum Levels in Adult Onset Still's Disease 71
From Localized Scleroderma to Systemic Sclerosis: Coexistence or Possible Evolution 70
Predictive Value of DLCO Reduction in Scleroderma Patients Without Cardio-Pulmonary Involvement at Baseline 69
High serum levels of silica nanoparticles in systemic sclerosis patients with occupational exposure: Possible pathogenetic role in disease phenotypes 68
Assessing Humoral Immuno-Inflammatory Pathways Associated with Respiratory Failure in COVID-19 Patients 68
Paraneoplastic rheumatic disorders: a narrative review 67
IP-10 in autoimmune thyroiditis 66
Bronchoalveolar lavage and response to cyclophosphamide in scleroderma alveolitis. 66
High interleukin-6 and tumor necrosis factor-alpha serum levels in hepatitis C infection associated or not with mixed cryoglobulinemia 66
Clinical Presentation of Connective Tissue Disease Patients with and without Interstitial Lung Disease: A Retrospective Study 65
Systemic Sclerosis and Idiopathic Portal Hypertension: Report of a Case and Review of the Literature 65
Serum 25-OH vitamin D levels in systemic sclerosis: analysis of 140 patients and review of the literature 65
Micro and nanoparticles as possible pathogenetic co-factors in mixed cryoglobulinemia 65
Heart Valve Abnormalities in Systemic Sclerosis Patients: A Multicenter Cohort Study and Review of the Literature 65
Rituximab in the treatment of patients with systemic sclerosis. Our experience and review of the literature 64
Scleroderma skin ulcers definition, classification and treatment strategies our experience and review of the literature 64
Capillaroscopic skin ulcer risk index: A new prognostic tool for digital skin ulcer development in systemic sclerosis patients 64
Incidence of thyroid disorders in systemic sclerosis: results from a longitudinal follow-up 63
Gynaecological Screening for Cervical and Vulvar Malignancies in a Cohort of Systemic Sclerosis Patients: Our Experience and Review of the Literature 63
LONG-TERM TREATMENT WITH RITUXIMAB IN SYSTEMIC SCLEROSIS MANAGEMENT: AN OVERVIEW OF THE CLINICAL EXPERIENCE FROM A REAL-LIFE SETTING 63
Effectiveness and safety of filgotinib in rheumatoid arthritis: a real-life multicentre experience 62
Impegno cardiaco nella sclerosi sistemica 62
Polymyositis following Pandemic Influenza A (H1N1) and 2009-10 Seasonal Trivalent Vaccines 62
Systematic review of 2008-2012 literature and update of recommendations for the use of methotrexate in rheumatic diseases, with a focus on rheumatoid arthritis 61
Platelet gel in the treatment of severe scleroderma skin ulcers 61
Feasibility, face, and content validity of quantitative computed tomography in interstitial lung disease related to connective tissue diseases 60
Use of 18F-fluorodeoxyglucose positron emission tomography-computed tomography in patients affected by polymyalgia rheumatica and persistent increase of acute phase reactants 59
Endocrine Manifestations of HCV-Positive Cryoglobulinemia 59
HCV-related autoimmune disorders in HCV chronic infection. 59
Predictive role of capillaroscopic skin ulcer risk index in systemic sclerosis: A multicentre validation study 59
Immunomodulation of CXCL10 secretion by hepatitis C virus: Could CXCL10 be a prognostic marker of chronic hepatitis C? 59
The treatment of skin ulcers in systemic sclerosis: use of granulocyte-colony stimulating factor (G-CSF) in 26 patients 58
High serum levels of CXCL11 in mixed cryoglobulinemia are associated with increased circulating levels of interferon-γ. 58
CXCL10 (alpha) and CCL2 (beta) chemokines in systemic sclerosis--a longitudinal study 58
High levels of circulating N-terminal pro-brain natriuretic peptide in patients with hepatitis C 58
Validation study of predictive value of capillaroscopic skin ulcer risk index (CSURI) in scleroderma patients treated with bosentan 58
Progression and prognosis of interstitial pneumonia with autoimmune features: a longitudinal, prospective, multi-centre study 57
Storia naturale della sclerosi sistemica in Italia. 57
The safety of iloprost in systemic sclerosis in a real-life experience 57
Treatment of HCV-related mixed cryoglobulinemia 57
Innovative use of magnesium oxide in the treatment of "neuralgia of the celiac plexus of rheumatic origin" by G. Moscati in 1923 57
Recombinant human erythropoietin stimulates vasculogenesis and wound healing in a patient with systemic sclerosis complicated by severe skin ulcers 56
Trattamento del dolore in reumatologia con oppioidi: nostra esperienza con ossicodone in pazienti con ulcere cutanee vasculitiche. 56
Vasculiti sistemiche 56
Predictive value of isolated DLCO reduction in systemic sclerosis patients without cardio-pulmonary involvement at baseline 56
Pancreatic Neuroendocrine Tumor (Pan-NET) Presented by Abdominal Pain: A Case Report and Literature Review 55
Sclerosing cholangitis may mimic radiological pattern of cholangiocarcinoma: Differential diagnosis and review of literature 55
Prevalence and Death Rate of COVID-19 in Autoimmune Systemic Diseases in the First Three Pandemic Waves. Relationship with Disease Subgroups and Ongoing Therapies 55
Viral infections and systemic sclerosis. 55
Osteomyelitis complicating scleroderma digital ulcers 55
Th1 and Th2 chemokine serum levels in systemic sclerosis in the presence or absence of autoimmune thyroiditis. 55
Hepatitis C virus infection and type 2 diabetes. 55
IFN-γ and TNF-α induce a different modulation of interleukin-6 in systemic sclerosis fibroblasts compared to healthy controls. 55
The Model for Early COvid-19 Recognition (MECOR) Score: A Proof-of-Concept for a Simple and Low-Cost Tool to Recognize a Possible Viral Etiology in Community-Acquired Pneumonia Patients during COVID-19 Outbreak 55
Systemic sclerosis and cryoglobulinemia: our experience with overlapping syndrome of scleroderma and severe cryoglobulinemic vasculitis and review of the literature 54
Serum a-Chemokine CXCL10 and b-Chemokine CCL2 Levels in HCV-Positive Cryoglobulinemia 54
Tocilizumab for the treatment of patients with rheumatoid arthritis and interstitial lung diseases: a case series 54
Practical suggestions on intravenous iloprost in Raynaud's phenomenon and digital ulcer secondary to systemic sclerosis: Systematic literature review and expert consensus 54
Oxycodone in the Long-Term Treatment of Chronic Pain Related to Scleroderma Skin Ulcers 53
Severe alopecia complicating systemic sclerosis 53
Patients with mixed cryoglobulinemia and HCV infection, in presence or absence of autoimmune thyroiditis, have high serum levels of (CXC motif) ligand (CXCL)9 and CXCL11 chemokines 53
Systemic sclerosis fibroblasts show specific alterations of interferon-γ and tumor necrosis factor-α-induced modulation of interleukin 6 and chemokine ligand 2. 53
I fattori di crescita nella rigenerazione tissutale: uso di gel piastrinico nelle ulcere cutanee associate a sclerosi sistemica. 53
Treatment of severe scleroderma skin ulcers with recombinant human erythropoietin 53
Totale 6.838
Categoria #
all - tutte 36.737
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 36.737


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021187 0 0 0 9 114 10 11 4 22 2 7 8
2021/2022816 77 126 2 6 143 12 127 31 34 9 26 223
2022/20231.838 139 80 57 182 185 329 10 265 458 18 65 50
2023/2024652 47 97 30 27 25 145 3 49 7 21 136 65
2024/20253.005 22 373 170 136 645 417 91 80 269 287 310 205
2025/20261.710 354 288 992 76 0 0 0 0 0 0 0 0
Totale 9.034